The North America alopecia treatment (hair loss) market is driven by a surge in hair loss cases stemming from medical conditions, poor dietary habits, sedentary lifestyles, aging, hormonal imbalances, and rising chronic diseases such as arthritis, cancer, hypertension, and depression, particularly among middle-aged individuals. Androgenetic alopecia, the main contributor to male hair loss, accounts for around 95 percent of cases. With over 800,000 individuals worldwide seeking hair loss solutions, the North American market experiences growth due to increased demand for effective treatments addressing the diverse causes of hair loss.
According to Data Bridge Market Research, the North America Alopecia Treatment (Hair Loss) Market was valued at USD 1,839.35 million in 2021 and is expected to reach USD 2,909.60 million by 2029, registering a CAGR of 5.90% during the forecast period of 2022 to 2029.
“Escalating prevalence of hair loss among the population drive the market growth”
The North America alopecia treatment (hair loss) market is driven by the escalating prevalence of hair loss among the population. Factors such as genetics, lifestyle changes, and stress contribute to a growing number of individuals experiencing hair loss concerns. This surge in prevalence has spurred greater demand for effective treatment options, propelling research and innovation in the field. As individuals seek solutions to address their hair loss, the market experiences an upswing in demand for therapies, creating opportunities for companies to develop and offer diverse treatments to cater to the rising needs of the North American population.
What restraints the growth of North America Alopecia Treatment (Hair Loss) Market?
“High costs associated with treatments”
The North America alopecia treatment (hair loss) market faces a constraint due to the high costs associated with treatments. The region's advanced healthcare infrastructure and access to cutting-edge therapies often come with elevated expenses, deterring some individuals from seeking or continuing treatments. The financial burden posed by treatments can limit their accessibility and affordability, impacting patient choices and adherence to regimens. High treatment costs may impede widespread adoption, potentially hindering the market's growth and restricting the availability of effective alopecia solutions for a broader population within North America.
Segmentation: North America Alopecia Treatment (Hair Loss) Market
The North America alopecia treatment (hair loss) market is segmented on the basis of drug type, indication, gender, diagnosis, route of administration, end-users, and distribution channel.
- On the basis of drug type, the North America alopecia treatment (hair loss) market is segmented into minoxidil, finasteride, and others.
- On the basis of indication, the North America alopecia treatment (hair loss) market is segmented into androgenic alopecia, alopecia areata, alopecia totalis, and others.
- On the basis of diagnosis, the North America alopecia treatment (hair loss) market is segmented into trichoscopy, Skin Biopsy, and others.
- On the basis of gender, the North America alopecia treatment (hair loss) market is segmented into male, female.
- On the basis of route of administration, the North America alopecia treatment (hair loss) market is segmented into oral, topical, parenteral, and others.
- On the basis of end-users, the North America alopecia treatment (hair loss) market is segmented into hospitals, specialty clinics, homecare, and others.
- On the basis of distribution channel, the North America alopecia treatment (hair loss) market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others.
To know more about the study visit, https://www.databridgemarketresearch.com/jp/reports/north-america-alopecia-treatment-hair-loss-market
Recent Developments in North America Alopecia Treatment (Hair Loss) Market
- In August 2021, Pfizer revealed encouraging top-line outcomes from a phase 2b/3 trial of ritlecitinib, a breakthrough in alopecia (hair loss) treatment. Ritlecitinib, a novel covalent kinase inhibitor, primarily targets Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family with exceptional selectivity. Laboratory experiments have shown that ritlecitinib hinders the function of signaling molecules and immune cells linked to hair loss in individuals with alopecia. This advancement potentially signifies a significant leap forward in addressing hair loss concerns, introducing a promising therapeutic avenue.
The Prominent Key Players Operating in the North America Alopecia Treatment (Hair Loss) Market Include:
- Johnson & Johnson Private Limited (U.S.)
- GlaxoSmithKline plc (U.K.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Cipla Inc. (U.S.)
- Endo International plc (Ireland)
- Zydus Cadila (India)
- Abbott (US)
- Aurobindo Pharma (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Perrigo Company plc (Ireland)
- Curallux, LLC. (U.S.)
- DR. KURT WOLFF GMBH & CO. KG (Germany)
- WOCKHARDT (India)
Above are the key players covered in the report, to know about more and exhaustive list of North America alopecia treatment (hair loss) market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: North America Alopecia Treatment (Hair Loss) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
